Free Trial

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$93.20 -2.79 (-2.90%)
Closing price 08/25/2025 03:59 PM Eastern
Extended Trading
$93.00 -0.20 (-0.22%)
As of 08/25/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INSP vs. PEN, STVN, GKOS, BLCO, IRTC, TMDX, SLNO, NVST, LIVN, and WRBY

Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry.

Inspire Medical Systems vs. Its Competitors

Penumbra (NYSE:PEN) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

Penumbra presently has a consensus price target of $300.47, suggesting a potential upside of 13.30%. Inspire Medical Systems has a consensus price target of $165.62, suggesting a potential upside of 77.69%. Given Inspire Medical Systems' higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than Penumbra.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
2 Strong Buy rating(s)
2.94
Inspire Medical Systems
0 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.54

Inspire Medical Systems has lower revenue, but higher earnings than Penumbra. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Penumbra$1.19B8.66$14.01M$3.7670.53
Inspire Medical Systems$802.80M3.43$53.51M$1.7353.88

In the previous week, Inspire Medical Systems had 9 more articles in the media than Penumbra. MarketBeat recorded 20 mentions for Inspire Medical Systems and 11 mentions for Penumbra. Inspire Medical Systems' average media sentiment score of 1.33 beat Penumbra's score of 0.92 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Penumbra
7 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
14 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

88.9% of Penumbra shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 5.0% of Penumbra shares are held by insiders. Comparatively, 2.3% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Penumbra has a net margin of 11.54% compared to Inspire Medical Systems' net margin of 6.17%. Penumbra's return on equity of 11.55% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Penumbra11.54% 11.55% 8.76%
Inspire Medical Systems 6.17%10.38%8.93%

Penumbra has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500.

Summary

Penumbra beats Inspire Medical Systems on 10 of the 17 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$2.84B$2.15B$5.82B$21.30B
Dividend YieldN/AN/A4.40%3.54%
P/E Ratio53.8837.4330.1428.85
Price / Sales3.4310.00435.1351.02
Price / Cash56.1853.5525.7818.23
Price / Book4.0510.749.424.69
Net Income$53.51M-$63.67M$3.27B$995.89M
7 Day Performance3.56%3.56%3.64%2.23%
1 Month Performance-27.77%0.59%3.52%2.46%
1 Year Performance-50.67%26.13%29.95%10.46%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
4.9374 of 5 stars
$93.20
-2.9%
$165.62
+77.7%
-51.3%$2.84B$802.80M53.881,246Positive News
PEN
Penumbra
4.7437 of 5 stars
$255.35
+0.9%
$300.47
+17.7%
+26.2%$9.96B$1.28B67.914,500Positive News
STVN
Stevanato Group
N/A€22.50
-0.5%
N/A+18.2%€6.81B€1.19B41.675,521
GKOS
Glaukos
4.7106 of 5 stars
$89.47
-0.4%
$127.42
+42.4%
-30.9%$5.13B$432.95M-54.22780Analyst Revision
BLCO
Bausch + Lomb
1.6062 of 5 stars
$14.49
-0.4%
$15.56
+7.4%
-10.5%$5.13B$4.79B-18.5713,500
IRTC
iRhythm Technologies
1.3017 of 5 stars
$157.93
-1.7%
$157.30
-0.4%
+136.7%$5.07B$591.84M-53.902,000Insider Trade
TMDX
TransMedics Group
2.7556 of 5 stars
$125.65
-1.5%
$123.00
-2.1%
-34.5%$4.28B$441.54M65.10210Positive News
Analyst Forecast
SLNO
Soleno Therapeutics
4.6161 of 5 stars
$68.09
-4.9%
$114.30
+67.9%
+47.0%$3.62BN/A-16.4530News Coverage
NVST
Envista
3.6875 of 5 stars
$20.75
+0.5%
$20.92
+0.9%
+13.1%$3.45B$2.51B64.8312,300
LIVN
LivaNova
1.6246 of 5 stars
$53.27
-0.8%
$59.29
+11.3%
+20.9%$2.91B$1.25B-13.692,900News Coverage
Positive News
WRBY
Warby Parker
2.174 of 5 stars
$27.38
+0.9%
$24.06
-12.1%
+68.8%$2.88B$771.32M-391.093,780Analyst Upgrade

Related Companies and Tools


This page (NYSE:INSP) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners